Aceto buys into bio-derived APIs
US chemicals firm Aceto has bought the German Pharma Waldhof business from Switzerland's Roche, making its first foray into the market for biologically-derived active pharmaceutical ingredients (APIs).
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs